LENZ Therapeutics (LENZ) Cash & Equivalents (2020 - 2026)
LENZ Therapeutics (LENZ) reported Cash & Equivalents of $24.21 million for Q2 2026, down 35.6% from $37.61 million a year earlier and down 2.3% from the prior quarter.
Powered by 
Analysis
LENZ Therapeutics (LENZ) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, LENZ Therapeutics posted Cash & Equivalents of $25.18 million, up 24.9% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $20.16 million in FY2024 (-42.6%), $35.14 million in FY2023 (-26.4%), $47.73 million in FY2022 (-87.3%) and $376.98 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q1 2025.
- Year over year, Cash & Equivalents gained in two of the last eight quarters, with an average decline of 38.2%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2023 (growth of 224.5%); the low point was Q1 2025 (a decline of 88.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $24.77 million (Q1 2026), $25.18 million (Q4 2025) and $25.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | LENZ Therapeutics | 119.07 Mn | 119.07 Mn | 5.21 Mn | 24.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.21 Mn |
| Mar 31, 2026 | 24.77 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Sep 30, 2025 | 25.40 Mn |
| Jun 30, 2025 | 37.61 Mn |
| Mar 31, 2025 | 23.04 Mn |
| Dec 31, 2024 | 20.16 Mn |
| Sep 30, 2024 | 41.05 Mn |
| Jun 30, 2024 | 84.04 Mn |
| Mar 31, 2024 | 200.36 Mn |
| Dec 31, 2023 | 35.14 Mn |
| Sep 30, 2023 | 182.99 Mn |
| Jun 30, 2023 | 128.51 Mn |
| Mar 31, 2023 | 69.81 Mn |
| Dec 31, 2022 | 47.73 Mn |
| Sep 30, 2022 | 56.39 Mn |
| Jun 30, 2022 | 75.17 Mn |
| Mar 31, 2022 | 185.07 Mn |
| Dec 31, 2021 | 376.98 Mn |
| Sep 30, 2021 | 394.80 Mn |
API Access
LENZ Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LENZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LENZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LENZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();